anti-CLDN6/CD3 bispecific antibody CTIM-76
Term · Oncology and biomedicine · MLC-T-ONC-010520
An Fc-silenced humanized immunoglobulin G1 (IgG1) bispecific antibody targeting both the tumor-associated antigen (TAA) claudin 6 (CLDN6; CLDN-6) and the T-cell surface antigen CD3, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, anti-CLDN6/CD3 bispecific antibody CTIM-76 targets and binds to both CLDN6 expressed on tumor cells and CD3 expressed on T cells. This activates and redirects cytotoxic T lymphocytes (CTLs) to CLDN6-expressing tumor cells, which leads to enhanced CTL-mediated killing of CLDN6-expressing tumor cells. CLDN6, a tight-junction protein and embryonic antigen, is overexpressed on a variety of tumor cells but is not or minimally expressed on normal, healthy adult cells.
| Identifier | MLC-T-ONC-010520 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD3/CLDN6 bispecific antibody CTIM-76; anti-Claudin-6/CD3 bispecific antibody CTIM-76; anti-CLDN6/anti-CD3 bispecific antibody CTIM-76; anti-CLDN6/CD3 T-cell engaging bispecific antibody CTIM-76; Claudin-6-directed bispecific antibody CTIM-76; CLDN6 T-cell engager antibody CTIM-76; CLDN6 x CD3 bispecific antibody CTIM-76; CLDN6 x CD3 T-cell engaging bispecific antibody CTIM-76; CLDN6-directed TCE CTIM-76 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010520",
"term": "anti-CLDN6/CD3 bispecific antibody CTIM-76",
"field": "Oncology and biomedicine",
"definition": "An Fc-silenced humanized immunoglobulin G1 (IgG1) bispecific antibody targeting both the tumor-associated antigen (TAA) claudin 6 (CLDN6; CLDN-6) and the T-cell surface antigen CD3, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, anti-CLDN6/CD3 bispecific antibody CTIM-76 targets and binds to both CLDN6 expressed on tumor cells and CD3 expressed on T cells. This activates and redirects cytotoxic T lymphocytes (CTLs) to CLDN6-expressing tumor cells, which leads to enhanced CTL-mediated killing of CLDN6-expressing tumor cells. CLDN6, a tight-junction protein and embryonic antigen, is overexpressed on a variety of tumor cells but is not or minimally expressed on normal, healthy adult cells.",
"synonyms": [
"anti-CD3/CLDN6 bispecific antibody CTIM-76",
"anti-Claudin-6/CD3 bispecific antibody CTIM-76",
"anti-CLDN6/anti-CD3 bispecific antibody CTIM-76",
"anti-CLDN6/CD3 T-cell engaging bispecific antibody CTIM-76",
"Claudin-6-directed bispecific antibody CTIM-76",
"CLDN6 T-cell engager antibody CTIM-76",
"CLDN6 x CD3 bispecific antibody CTIM-76",
"CLDN6 x CD3 T-cell engaging bispecific antibody CTIM-76",
"CLDN6-directed TCE CTIM-76"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cldn6-cd3-bispecific-antibody-ctim-76/"
}
Record 1,611 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.